Briefing: Lack of FDA Advisory Committees Raises Concerns

← DOCKET/WORLD
Briefing: Lack of FDA Advisory Committees Raises ConcernsStrategic angle: Growing worries about the FDA's diminishing use of advisory committees for public discourse.
by Editorial Staff|Mar 9, 2026|1 MIN READ|WORLD

FDA is reportedly shunning advisory committees.

Concerns from drugmakers, patients, and doctors.

Potential implications for drug approval processes.